RG
TDOC icon

Redmile Group’s Teladoc Health TDOC Stock Holding History

Redmile Group’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-461,880
Closed -$30.7M – 82
2019
Q2 		$30.7M Buy
461,880
+21,980
+5% +$1.28M 0.87% 35
2019
Q1 		$24.5M Buy
439,900
+244,300
+125% +$14.9M 0.72% 42
2018
Q4 		$9.7M Sell
195,600
-139,100
-42% -$8.51M 0.39% 50
2018
Q3 		$28.9M Buy
334,700
+103,700
+45% +$7.39M 0.89% 42
2018
Q2 		$13.4M Sell
231,000
-42,200
-15% -$2.06M 0.46% 50
2018
Q1 		$11M Buy
273,200
+123,200
+82% +$4.65M 0.43% 49
2017
Q4 		$5.23M Buy
+150,000
New +$4.98M 0.23% 56

Other funds holding TDOC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Redmile Group's TDOC Position: Q3 2019 in Review

Redmile Group sold out of Teladoc Health (TDOC) in Q3 2019, closing a stake of 461,880 shares — an estimated $30.7M sold.

Redmile Group first reported a position in TDOC in Q4 2017 and held it in 7 quarters. The position peaked at $30.7M in Q2 2019. 378 funds tracked by Wall St. Rank hold TDOC as of Q3 2019.

  • Redmile Group reported no remaining Teladoc Health position as of Q3 2019 after selling out during the quarter.
  • Redmile Group sold 461,880 Teladoc Health shares in Q3 2019, an estimated $30.7M.
  • Redmile Group first reported a position in Teladoc Health in Q4 2017 and held it in 7 quarters.
  • Redmile Group's Teladoc Health position peaked at $30.7M in Q2 2019.
  • 378 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2019.

Based on Redmile Group's 13F filing for Q3 2019, filed 14 Nov 2019.